The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Antimicrobial peptides: a new class of antimalarial drugs?
|
|---|---|
| Published in |
Frontiers in Pharmacology, December 2014
|
| DOI | 10.3389/fphar.2014.00275 |
| Pubmed ID | |
| Authors |
Nuno Vale, Luísa Aguiar, Paula Gomes |
| Abstract |
A range of antimicrobial peptides (AMP) exhibit activity on malaria parasites, Plasmodium spp., in their blood or mosquito stages, or both. These peptides include a diverse array of both natural and synthetic molecules varying greatly in size, charge, hydrophobicity, and secondary structure features. Along with an overview of relevant literature reports regarding AMP that display antiplasmodial activity, this review makes a few considerations about those molecules as a potential new class of antimalarial drugs. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Switzerland | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 189 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 3 | 2% |
| Sweden | 1 | <1% |
| Portugal | 1 | <1% |
| Kenya | 1 | <1% |
| Unknown | 183 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 39 | 21% |
| Student > Master | 30 | 16% |
| Researcher | 22 | 12% |
| Student > Bachelor | 21 | 11% |
| Student > Doctoral Student | 11 | 6% |
| Other | 18 | 10% |
| Unknown | 48 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 46 | 24% |
| Agricultural and Biological Sciences | 35 | 19% |
| Chemistry | 25 | 13% |
| Medicine and Dentistry | 10 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Other | 9 | 5% |
| Unknown | 55 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2015.
All research outputs
#14,206,722
of 22,774,233 outputs
Outputs from Frontiers in Pharmacology
#4,641
of 16,011 outputs
Outputs of similar age
#186,848
of 353,125 outputs
Outputs of similar age from Frontiers in Pharmacology
#18
of 62 outputs
Altmetric has tracked 22,774,233 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,011 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,125 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.